Lucid Diagnostics (LUCD) Net Shares Issued and Repurchased (2021 - 2026)

Lucid Diagnostics (LUCD) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 61.66% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (up 61.66% YoY), and the FY2025 full-year result was $2.3 million, down 38.49% from the prior year.
• Net Shares Issued and Repurchased fell to $2.2 million in Q1 2026 per LUCD's latest filing, from $2.3 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $3.7 million in Q4 2024 and bottomed at $1.4 million in Q1 2025.
• Historically, Net Shares Issued and Repurchased has averaged $2.7 million across 5 years, with a median of $2.5 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased soared 458.71% in 2022, then slumped 54.05% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.4 million in 2022, then soared by 52.98% to $3.6 million in 2023, then climbed by 3.18% to $3.7 million in 2024, then sank by 38.49% to $2.3 million in 2025, then retreated by 2.94% to $2.2 million in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.2 million, $2.3 million, and $1.4 million for Q1 2026, Q4 2025, and Q1 2025 respectively.